Colony-stimulating factors for drug-induced neutropenia (other than antineoplastic- or HIV-associated).
This article is an executive summary of the Blue Cross Blue Shield Technology Evaluation Center (TEC) Assessment "Colony-Stimulating Factors for Drug-Induced Neutropenia (Other than Antineoplastic- or HIV-Associated)" Volume 9, No. 23, 1994. The complete assessment, which includes background information, methods, formulation of the assessment, review of evidence, conclusions, and references are available to Blue Cross Blue Shield TEC Program subscribers only.  For subscription information, contact the program at (312) 440-6080.
D054598:Blue Cross Blue Shield Insurance Plans; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D009503:Neutropenia / Q000188:drug therapy / Q000401:mortality*; D017063:Outcome Assessment, Health Care; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration